Alexandra Miller, MD, PhD

Neurologist

Conditions Treated

Memorial Sloan Kettering neurologist Alexandra Miller
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. Phone Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

  • Clinical Expertise: Primary Brain Tumors Including Glioblastoma; Anaplastic Glioma; Low-grade Glioma; Ependymoma; Meningioma; and Central Nervous System Lymphoma; Brain Metastases (Including Leptomeningeal Disease); Neurologic Complications of Cancer
  • Awards and Honors: American Society of Clinical Oncology Young Investigator Award (2017)
  • Languages Spoken: English
  • Education: MD, PhD, Yale University School of Medicine
  • Residencies: Neurology – NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowships: Neuro-Oncology – Memorial Sloan Kettering Cancer Center
  • Board Certifications: Neurology; Neuro-Oncology

New Patient Appointments

Make an appointment Arrow rightAn icon showing an arrow pointing to the right.

Call 866-886-9807

See My Colleagues

Publications

Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism.Sood A, Miller AM, Brogi E, Sui Y, Armenia J, McDonough E, Santamaria-Pang A, Carlin S, Stamper A, Campos C, Pang Z, Li Q, Port E, Graeber TG, Schultz N, Ginty F, Larson SM, Mellinghoff IK. JCI Insight. 2016 May 5;1(6). pii: e87030.

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Rohle D, Popovici-Muller J, Palaskas N, Turcan S, Grommes C, Campos C, Tsoi J, Clark O, Oldrini B, Komisopoulou E, Kunii K, Pedraza A, Schalm S, Silverman L, Miller A, Wang F, Yang H, Chen Y, Kernytsky A, Rosenblum MK, Liu W, Biller SA, Su SM, Brennan CW, Chan TA, Graeber TG, Yen KE, Mellinghoff IK. Science. 2013 May 3;340(6132):626-30. doi: 10.1126/science.1236062. Epub 2013 Apr 4.

Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma. Diamond EL, Prigerson HG, Correa DC, Reiner A, Panageas K, Kryza-Lacombe M, Buthorn J, Neil EC, Miller AM, DeAngelis LM, Applebaum AJ. Neuro Oncol. 2017 Oct 19;19(11):1532-1541. doi: 10.1093/neuonc/nox117.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.

Related topics:

Memorial Sloan Kettering neurology department chair Lisa DeAngelis and research nurse Malbora Manne work to provide the best possible outcomes for people with brain tumors. Primary Brain Tumors Arrow rightAn icon showing an arrow pointing to the right.
Rockefeller Outpatient Pavilion Rockefeller Outpatient Pavilion Arrow rightAn icon showing an arrow pointing to the right.
Neurology Department Chair Lisa DeAngelis, who is also MSK’s acting Physician-in-Chief, has led numerous brain tumor therapeutic trials. Metastatic Brain Tumors & Secondary Brain Cancer Arrow rightAn icon showing an arrow pointing to the right.